RNU7-200P

Across TCGA pan-cancer cohorts, RNU7-200P RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated RNU7-200P data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher RNU7-200P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU7-200P expression acts as an unfavorable survival marker, although some lineages such as LUSC and ESCA show a favorable association.

READ, THCA, and LIHC are the cancer types where RNU7-200P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	DFS	Tertile	All	0.246	0.715	<.001	135	view →
THCA	OS	Tertile	IV	0.360	0.875	<.001	54	view →
LIHC	OS	Tertile	III,IV	0.131	0.662	<.001	54	view →
CESC	OS	Tertile	IV	0.149	0.614	.002	36	view →
DLBC	OS	Tertile	II,III,IV	0.115	0.839	<.001	36	view →
KIRP	DFS	Tertile	II,III,IV	0.146	0.702	.001	30	view →
MESO	DFS	Tertile	III,IV	0.170	0.386	.016	18	view →
TGCT	OS	Tertile	All	0.817	0.968	.027	18	view →
SKCM	DFS	Tertile	All	0.535	0.763	.022	12	view →
PCPG	OS	Tertile	All	0.888	1.000	.002	9	view →
LUSC	OS	Tertile	III,IV	0.678	0.258	.025	6	view →
ESCA	DFS	Median	All	0.913	0.551	.041	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

RNU7-200P–READ (DFS)

Open the READ breakdown →